Serum Institute seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adults
Covid-19 vaccine India: The Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for adults who have been administered two doses of either Covishield or Covaxin.